Thus, these serum chemokine analyses suggest that serum concentrations of CXCL9, CXCL10, and CCL25 might be useful biomarkers for the diagnosis and monitoring of disease activity in AIP/IgG4-RD. The gene discussed is CXCL10; the disease is autoimmune pancreatitis.